RESUMO
INTRODUCTION: Scarring after burn injuries remains one of the major challenges in burn medicine and is the subject of current research. Accurate and high-quality assessment of scars is needed to enable exact outcome evaluation of different treatments. Our aim was to evaluate the most common subjective scar evaluation scores-the POSAS (Patient and Observer Scar Assessment Scale) and VSS (Vancouver Scar Scale)-in comparison with the objective device Mexameter® for colour evaluation. METHODS: A prospective monocentre study was performed, which included 120 examined scar areas of 60 patients with third degree burns who had received skin grafts between 1975 and 2018 with a total burned surface area (TBSA) > 2%. Two different scar areas in comparison with one healthy skin area concerning 'colour', 'pigmentation', and 'vascularization' were evaluated by the Mexameter® MX 18, the OSAS, and the VSS by the same examiner, as well as the PSAS by the patient. RESULTS: The mean TBSA of the 60 patients was 24.3%. In the OSAS, 61% of the scars were evaluated as 'hyper-', 19% as 'hypo-', and 19% as 'mix-pigmented'. Furthermore, 65% of the scars were estimated as highly vascularized. In the Mexameter®, the melanin index values of the scar areas compared to the healthy skin areas showed a small difference of 12 (p < 0.05). The mean difference of erythema between the scar and the healthy skin areas was 84 (p < 0.001). For the Mexameter®, moderate correlations were found when comparing 'erythema' with the OSAS category 'vascularization' (r = 0.33, p < 0.05) and 'melanin' with the OSAS parameter 'pigmentation' (r = 0.28, p < 0.05). When comparing the Mexameter® measurements to the OSAS questionnaire, 27% of the scars were wrongly evaluated as 'hyperpigmented' by the observer and 21% as 'hypervascularized', while showing low measurements in the device. Additionally, a novel Mexameter® ordinal scare scale was calculated. CONCLUSION: In this study, we were able to show on a relatively large patient population that with the Mexameter®, the subjectivity of the scar colour assessment by examiner/patient can be overcome, but precise differentiation can still be ensured with subjective evaluation tools. We further introduced a novel Mexameter® Scar Scale. It is necessary to further investigate the vast range of objective devices and develop scar panels for with an incorporation of objective and subjective devices to further improve reliability with reduced bias in terms of scar assessment.
Assuntos
Queimaduras , Apneia Obstrutiva do Sono , Humanos , Cicatriz/etiologia , Cicatriz/patologia , Estudos Prospectivos , Reprodutibilidade dos Testes , Cor , Queimaduras/complicações , Queimaduras/terapia , Eritema/etiologia , MelaninasRESUMO
BACKGROUND AND OBJECTIVES: Home-use intense pulsed light (IPL) hair removal devices are convenient for consumers. Consumer safety associated with home-use IPL devices, however, remains a subject of interest. In this descriptive analysis, we assessed the most commonly reported adverse events (AEs) for a home-use IPL device from postmarketing surveillance and qualitatively compared these with AEs from clinical studies and medical device reports of home-use IPL treatments. MATERIALS AND METHODS: For this analysis of voluntary reports, we queried a distributor's postmarketing database for IPL devices for the period beginning January 1, 2016, to December 31, 2021. All sources of comments, for example, phone, e-mail, company-sponsored web sites, were included in the analysis. AE data were coded according to the Medical Dictionary for Regulatory Activities (MedDRA) terminology. Also, we conducted a PubMed search to identify AE profiles from existing literature on home-use IPL devices and we searched the Manufacturer and User Facility Device Experience (MAUDE) database for reports on home-use IPL devices. These results were qualitatively compared to the data in the postmarketing surveillance database. RESULTS: A total of 1692 cases involving IPL were identified from voluntary reports of AEs between 2016 and 2021. The shipment-adjusted reporting rate for AE cases (number of AE cases/100,000 shipped IPL devices) was 67/100,000 during this 6-year period. The most commonly reported AEs were pain of skin 27.8% (470/1692), "thermal burn" 18.7% (316/1692), and erythema 16.0% (271/1692). Among the top 25 AEs reported, no unexpected health events were observed. The reported AEs were qualitatively similar to the pattern seen in clinical studies and the MAUDE database associated with such home-use IPL treatments. CONCLUSION: This is the first such report documenting AEs for home-use IPL hair removal from a postmarketing surveillance program. These data are supportive of the safety of such home-use low-fluence IPL technology.
Assuntos
Remoção de Cabelo , Terapia de Luz Pulsada Intensa , Humanos , Remoção de Cabelo/efeitos adversos , Pele , Eritema/etiologia , Terapia de Luz Pulsada Intensa/métodos , DorRESUMO
Skin erythema may present owing to many causes. One of the common causes is prolonged exposure to sunrays. Other than sun exposure, skin erythema is an accompanying sign of dermatologic diseases, such as psoriasis and acne. Quantifying skin erythema in patients enables the dermatologist to assess the patient's skin health. Quantitative assessment of skin erythema has been the focus of several studies. The clinical standard for erythema evaluation is visual assessment; however, this standard has some deficiencies. For instance, visual assessment is subjective and ineffectual for precise color information exchange. To overcome these limitations, in the past three decades various methodologies have been developed in an attempt to achieve objective erythema assessments, such as diffuse reflectance spectroscopy and both optical and nonoptical systems. This review considers the studies published during the past three decades and discusses the performance, the mathematical tactics for computation, and the limited capabilities of erythema assessment techniques for cutaneous diseases. The achievements and limitations of the current techniques in erythema assessment are presented. The advantages and development trends of optical and nonoptical methods are presented to make the reader aware of the present technological advances and their potential for dermatological disease research.
Assuntos
Eritema , Psoríase , Eritema/diagnóstico , Eritema/etiologia , Humanos , Pele , Pigmentação da PeleRESUMO
In 1978, the FDA Advisory Panel proposed both indoor and natural sunlight SPF testing methods but reverted to indoor testing only in 1993. Today's sunscreen sun protection and broad-spectrum claims are based on mandated clinical tests using solar simulators and in vitro spectrophotometers. This research evaluated the protection of 10 high-SPF (30-110), broad-spectrum sunscreen products, as well as 6 sun-protective fabrics against natural sunlight in Arequipa, Peru. Each of the 17 subjects was exposed to natural sunlight for 1 h and 59 min under clear skies, with temperatures and humidity similar to those in an indoor clinical laboratory. Test sites were photographed 16-24 h later. Four dermatologists evaluated the photographs for erythema and persistent pigment darkening (PPD). Perceptible sun-induced skin injury (sunburn and/or pigmentation) was detected at 97% of the sunscreen-protected scores. The most sun-sensitive subjects obtained the least erythema protection. The higher the SPF was, the higher the erythema protection, but the intensity of PPD was also higher. The 2 sunscreens using only FDA-approved sunscreen filters rated 30 SPF and 45+ SPF performed poorly: Eighty-one percent of the 136 scores were graded 1 minimal erythema dose or higher erythema, achieving, at a maximum, SPF of 5-7 in natural sunlight. Sun-protective fabrics tested provided excellent sun protection. The erythema and PPD observed through the sunscreens in less than 2 h are incongruous with the broad-spectrum, high-SPF sunscreen claims. Reapplying these sunscreens and staying in the sun longer, as stated on the product labels, would have subjected the subjects to even more UV exposure. High-SPF, broad-spectrum sunscreen claims based on indoor solar simulator testing do not agree with the natural sunlight protection test results.
Assuntos
Roupa de Proteção/normas , Fator de Proteção Solar/métodos , Luz Solar/efeitos adversos , Protetores Solares/química , Têxteis/normas , Avaliação Pré-Clínica de Medicamentos/métodos , Avaliação Pré-Clínica de Medicamentos/normas , Eritema/etiologia , Eritema/prevenção & controle , Feminino , Voluntários Saudáveis , Humanos , Masculino , Peru , Pele/efeitos dos fármacos , Pele/efeitos da radiação , Pigmentação da Pele/efeitos dos fármacos , Pigmentação da Pele/efeitos da radiação , Fator de Proteção Solar/normas , Protetores Solares/administração & dosagem , Protetores Solares/normasRESUMO
Skin cancer (SC) is a widely spread disease in the USA, Canada, and Australia. Skin cancer patients may be treated by many different techniques including radiation therapy. However, radiation therapy has side effects, which may range from skin erythema to skin necrosis. As erythema is the early evidence of exposure to radiation, monitoring erythema is important to prevent more severe reactions. Visual assessment (VA) is the gold standard for evaluating erythema. Nevertheless, VA is not ideal, since it depends on the observer's experience and skills. Digital photography and hyperspectral imaging (HSI) are optical techniques that provide an opportunity for objective assessment of erythema. Erythema indices were computed from the spectral data using Dawson's technique. The Dawson relative erythema index proved to be highly correlated (97.1 %) with clinical visual assessment scores. In addition, on the 7th session of radiation therapy, the relative erythema index differentiates with 99 % significance between irradiated and non-radiated skin regions. In this study, HSI is compared to digital photography for skin erythema statistical classification.
Assuntos
Eritema , Fotoquimioterapia , Eritema/etiologia , Humanos , Imageamento Hiperespectral , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes , Projetos Piloto , PeleAssuntos
Eritema/tratamento farmacológico , Rosácea/tratamento farmacológico , Administração Cutânea , Agonistas alfa-Adrenérgicos/administração & dosagem , Agonistas alfa-Adrenérgicos/economia , Eritema/etiologia , Humanos , Oximetazolina/administração & dosagem , Oximetazolina/economia , Rosácea/complicações , Creme para a Pele/administração & dosagemRESUMO
The lack of validated rosacea assessment tools is a hurdle in assessing rosacea severity. This article discusses a valid and reliable rosacea severity self-assessment tool (RSAT) to measure rosacea severity. To determine test-retest validity, participants completed the self-assessment twice. A blinded physician graded the participant's disease severity with the Investigator Global Severity (IGS) score. Pearson correlations were used to assess the relationship between the self-assessment measure and the IGS. Test-retest RSAT measurements were correlated. The RSAT represents a valid and reliable tool. This tool may facilitate determination of rosacea severity in survey research studies.
Assuntos
Autoavaliação Diagnóstica , Rosácea/complicações , Rosácea/diagnóstico , Inquéritos e Questionários , Eritema/etiologia , Feminino , Humanos , Masculino , Reprodutibilidade dos Testes , Rinofima/etiologia , Índice de Gravidade de Doença , Avaliação de SintomasAssuntos
Assistência Ambulatorial , Autocuidado , Terapia Ultravioleta , Vitiligo/radioterapia , Assistência Ambulatorial/economia , Estudos Transversais , Eritema/etiologia , Humanos , Visita a Consultório Médico/economia , Autocuidado/economia , Índice de Gravidade de Doença , Pigmentação da Pele/efeitos da radiação , Terapia Ultravioleta/efeitos adversos , Terapia Ultravioleta/economiaRESUMO
The assessment of the signs of aging within eyes area in cutometric (skin elasticity) and mexametric (discoloration and severity of erythema) examination after the treatment with: non-ablative fractional laser, non-ablative radiofrequency (RF) and intense light source (IPL). This study included 71 patients, aged 33-63 years (the average age was 45.81) with Fitzpatrick skin type II and III. 24 patients received 5 successive treatment sessions with a 1,410-nm non-ablative fractional laser in two-week intervals, 23 patients received 5 successive treatment sessions with a non-ablative RF in one-week intervals and 24 patients received 5 successive treatment sessions with an IPL in two-week intervals. The treatment was performed for the skin in the eye area. The Cutometer and Mexameter (Courage + Khazaka electronic) reference test was used as an objective method for the assessment of skin properties: elasticity, skin pigmentation and erythema. Measurements of skin elasticity were made in three or four sites within eye area. The results of cutometric measurements for R7 showed the improvement in skin elasticity in case of all treatment methods. The largest statistically significant improvement (p < .0001) was observed in case of laser and RF, during treatment sessions, at sites at upper and lower eyelid. The smallest change in skin elasticity for the laser, RF and IPL - p = .017, p = .003 and p = .001, respectively-was observed in a site within the outer corner of the eye. In all sites of measurements and for all methods, the greatest improvement in skin elasticity was demonstrated between the first and second measurement (after 3rd procedures). The majority of the results of mexametric measurements-MEX (melanin level) and ERYT (the severity of erythema) are statistically insignificant. Fractional, non-ablative laser, non-ablation RF and intense light source can be considered as methods significantly affecting elasticity and to a lesser extent erythema and skin pigmentation around the eyes. Fractional non-ablative laser is a method which, in comparison to other methods, has the greatest impact on skin viscoelasticity. These procedures are well tolerated and are associated with a low risk of side effects.
Assuntos
Técnicas Cosméticas/instrumentação , Terapia a Laser/instrumentação , Lasers Semicondutores/uso terapêutico , Tratamento por Radiofrequência Pulsada , Rejuvenescimento , Envelhecimento da Pele/efeitos da radiação , Adulto , Técnicas Cosméticas/efeitos adversos , Elasticidade , Desenho de Equipamento , Eritema/etiologia , Humanos , Terapia a Laser/efeitos adversos , Lasers Semicondutores/efeitos adversos , Pessoa de Meia-Idade , Tratamento por Radiofrequência Pulsada/efeitos adversos , Pigmentação da Pele/efeitos da radiação , Fatores de Tempo , Resultado do TratamentoRESUMO
Ultraviolet radiation (UVR) has been associated with various health outcomes, including skin cancers, vitamin D insufficiency, and multiple sclerosis. Measurement of UVR has been difficult, traditionally relying on subject recall. We investigated trends in satellite-derived UVB from 1978 to 2014 within the continental United States (US) to inform UVR exposure assessment and determine the potential magnitude of misclassification bias created by ignoring these trends. Monthly UVB data remotely sensed from various NASA satellites were used to investigate changes over time in the United States using linear regression with a harmonic function. Linear regression models for local geographic areas were used to make inferences across the entire study area using a global field significance test. Temporal trends were investigated across all years and separately for each satellite type due to documented differences in UVB estimation. UVB increased from 1978 to 2014 in 48% of local tests. The largest UVB increase was found in Western Nevada (0.145 kJ/m2 per five-year increment), a total 30-year increase of 0.87 kJ/m2. This largest change only represented 17% of total ambient exposure for an average January and 2% of an average July in Western Nevada. The observed trends represent cumulative UVB changes of less than a month, which are not relevant when attempting to estimate human exposure. The observation of small trends should be interpreted with caution due to measurement of satellite parameter inputs (ozone and climatological factors) that may impact derived satellite UVR nearly 20% compared to ground level sources. If the observed trends hold, satellite-derived UVB data may reasonably estimate ambient UVB exposures even for outcomes with long latency phases that predate the satellite record.
Assuntos
Monitoramento Ambiental , Eritema/etiologia , Raios Ultravioleta/efeitos adversos , Humanos , Nevada , Doses de Radiação , Medição de Risco , Fatores de TempoRESUMO
Acute skin toxicities from ionizing radiation (IR) are a common side effect from therapeutic courses of external beam radiation therapy (RT) and negatively impact patient quality of life and long term survival. Advances in the understanding of the biological pathways associated with normal tissue toxicities have allowed for the development of interventional drugs, however, current response studies are limited by a lack of quantitative metrics for assessing the severity of skin reactions. Here we present a diffuse optical spectroscopic (DOS) approach that provides quantitative optical biomarkers of skin response to radiation. We describe the instrumentation design of the DOS system as well as the inversion algorithm for extracting the optical parameters. Finally, to demonstrate clinical utility, we present representative data from a pre-clinical mouse model of radiation induced erythema and compare the results with a commonly employed visual scoring. The described DOS method offers an objective, high through-put evaluation of skin toxicity via functional response that is translatable to the clinical setting.
Assuntos
Radiodermite/patologia , Pele/efeitos da radiação , Análise Espectral/métodos , Animais , Modelos Animais de Doenças , Eritema/etiologia , Eritema/patologia , Camundongos , Qualidade de Vida , Radiação Ionizante , Radiodermite/etiologiaRESUMO
BACKGROUND/PURPOSE: Sunscreen efficacy is usually expressed by the sun protection factor (SPF) which is calculated by establishing the minimum erythematous dose (MED), i.e. the smallest amount of energy required to trigger erythema. Efforts have been made to harmonise SPF testing but in vivo SPF methodology could still be improved to reduce its variability. This article proposes a means of standardising MED evaluations through the development and validation of an MED assessment system based on image analysis. METHODS: The MED assessment system comprises a camera combined with a black tube for acquiring pictures of the skin surface. Specific software was then developed to analyse these pictures to determine the MED based on the shape, size and colour of the exposed zones. The MED assessment system was validated through two studies. The first study was designed to assess the correlation between three expert graders who visually determined the MEDs in five subjects on whom three different suncare products (SPF 6, SPF 30 and SPF 50+) were tested. The second study correlated results obtained from one expert grader with those from a grader assisted by the new MED assessment system. RESULTS: Results of the first study showed substantial variation between graders, with kappa agreement as low as 0.59 (percentage error 19.7%). Results of the study assessing correlation between the expert grader and the grader facilitated by the new MED assessment device showed better correlation, with a kappa value of 0.75 and percentage error of 9.61%. CONCLUSION: A high degree of inter-grader variability was seen when MED was assessed by expert graders. The new MED assessment system provides background colour correction and standardisation to enable accurate MED determination. A high level of correlation was seen between the expert grader and the new MED assessment system, thus demonstrating its potential utility in more accurate and homogenous MED evaluations. Future multicentre studies are required to improve and validate the standardised MED determination for suncare products and to further evaluate the role of this new MED assessment system. However, these preliminary results are encouraging and may set the scene for this new MED assessment system to become the standard of the future.
Assuntos
Eritema/etiologia , Eritema/prevenção & controle , Radiometria/normas , Pele/efeitos dos fármacos , Pele/efeitos da radiação , Protetores Solares/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Dermoscopia/instrumentação , Dermoscopia/normas , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Eritema/patologia , França , Humanos , Iluminação/instrumentação , Iluminação/normas , Pessoa de Meia-Idade , Fotografação/instrumentação , Fotografação/normas , Radiometria/instrumentação , Valores de Referência , Pele/patologia , Protetores Solares/normas , Raios Ultravioleta/efeitos adversosRESUMO
The aim of this work was to verify the indicated maximum entrance surface air kerma (ESAK) using a GE Innova IGS 520 imaging system during cardiac interventional procedures. Gafchromic XR RV3 films were used for the patient measurements to monitor the maximum ESAK. The films were scanned and calibrated to measure maximum ESAK. Thermoluminescent dosemeters were used to measure the backscatter factor from an anthropomorphic thorax phantom. The measured backscatter factor, 1.53, was in good agreement with Monte Carlo simulations but higher than the one used by the imaging system, 1.20. The median of the ratio between indicated maximum ESAK and measured maximum ESAK was 0.68. In this work, the indicated maximum ESAK by the imaging system's dose map model underestimates the measured maximum ESAK by 32 %. The threshold ESAK for follow-up procedures for patient with skin dose in excess of 2 Gy will be reduced to 1.4 Gy.
Assuntos
Dosimetria Fotográfica/instrumentação , Fluoroscopia/métodos , Radiologia Intervencionista/métodos , Pele/efeitos da radiação , Ar , Antropometria , Calibragem , Eritema/etiologia , Dosimetria Fotográfica/métodos , Humanos , Método de Monte Carlo , Imagens de Fantasmas , Doses de Radiação , Espalhamento de Radiação , Raios XRESUMO
INTRODUÇÃO: Leucodermias solares geram preocupações estéticas para os pacientes e nenhum tratamento é primeira escolha na literatura. MÉTODOS: Ensaio clínico randomizado, monocego. Foram selecionados nove pacientes, com presença de pelo menos 10 lesões de leucodermia em cada antebraço, totalizando 180 lesões. Avaliou-se a eficácia de 2 sessões do MMP® com 5-Fluoracil comparado com MMP® sem medicação e 5-Fluoracil intralesional para tratamento das leucodermias de antebraços. RESULTADOS: Das lesões avaliadas segundo a eficácia, todas apresentaram repigmentação, o que indica melhora clínica com qualquer dos 3 tratamentos. O 5-FU isolado foi o mais eficaz, com significância estatística, seguido do MMP®+5-FU. O MMP® sem medicação foi o menos eficaz. Dentre os efeitos adversos, hiperpigmentação, ardor, prurido e dor não tiveram significância estatística ao fim do estudo. O eritema do MMP®+5-FU foi significativamente superior na maioria das visitas. Todos os pacientes relataram melhora clínica após os procedimentos. Maior relato de dor com a técnica de MMP® com ou sem medicação. DISCUSSÃO: A melhor eficácia do 5-FU em relação ao MMP®+5-Fluoracil poderia ser explicada pela diferente técnica de aplicação da medicação. Supõe-se que o MMP® foi o menos eficaz devido a não utilização do 5-FU. Não existem na literatura trabalhos com o uso de 5-FU intralesional ou MMP®+5-FU ou MMP® isolado para tratar leucodermias solares. O eritema persistente do MMP®+5-FU seria resultado do trauma somado a reação inflamatória induzida pelo 5-FU. CONCLUSÃO: Após 2 sessões de tratamento, o 5-FU mostrou-se o mais eficaz e com maior tolerabilidade pelos pacientes. Descritores: Leucodermia solar; 5-Fluoracil; MMP®; Dermatologia
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Sistemas de Liberação de Medicamentos/instrumentação , Hipopigmentação/terapia , Fluoruracila/uso terapêutico , Microinjeções , Agulhas , Antimetabólitos/uso terapêutico , Prurido/etiologia , Urticária/etiologia , Medição da Dor , Injeções Intradérmicas , Resultado do Tratamento , Sistemas de Liberação de Medicamentos/efeitos adversos , Hiperpigmentação/etiologia , Eritema/etiologia , Fluoruracila/administração & dosagem , Microinjeções/efeitos adversos , Antimetabólitos/administração & dosagemRESUMO
PURPOSE: Skin toxicity caused by radiotherapy has been visually classified into discrete grades. The present study proposes an objective and continuous assessment method of skin erythema in digital images taken under arbitrary lighting conditions, which is the case for most clinical environments. The purpose of this paper is to show the feasibility of the proposed method. METHODS: Clinical data were gathered from six patients who received carbon beam therapy for lung cancer. Skin condition was recorded using an ordinary compact digital camera under unfixed lighting conditions; a laser Doppler flowmeter was used to measure blood flow in the skin. The photos and measurements were taken at 3 h, 30, and 90 days after irradiation. Images were decomposed into hemoglobin and melanin colors using independent component analysis. Pixel values in hemoglobin color images were compared with skin dose and skin blood flow. The uncertainty of the practical photographic method was also studied in nonclinical experiments. RESULTS: The clinical data showed good linearity between skin dose, skin blood flow, and pixel value in the hemoglobin color images; their correlation coefficients were larger than 0.7. It was deduced from the nonclinical that the uncertainty due to the proposed method with photography was 15%; such an uncertainty was not critical for assessment of skin erythema in practical use. CONCLUSIONS: Feasibility of the proposed method for assessment of skin erythema using digital images was demonstrated. The numerical relationship obtained helped to predict skin erythema by artificial processing of skin images. Although the proposed method using photographs taken under unfixed lighting conditions increased the uncertainty of skin information in the images, it was shown to be powerful for the assessment of skin conditions because of its flexibility and adaptability.
Assuntos
Eritema/etiologia , Radioterapia com Íons Pesados/efeitos adversos , Imagem Molecular , Pele/efeitos da radiação , Idoso , Eritema/metabolismo , Feminino , Humanos , Neoplasias Pulmonares/radioterapia , Masculino , Pessoa de Meia-Idade , Pigmentação/efeitos da radiação , Pele/metabolismoRESUMO
BACKGROUND: Lyme disease patients with erythema migrans are said to have post-treatment Lyme disease symptoms (PTLDS) if there is persistence of subjective symptoms for at least 6 months following antibiotic treatment and resolution of the skin lesion. The purpose of this study was to characterize PTLDS in patients with culture-confirmed early Lyme disease followed for >10 years. METHODS: Adult patients with erythema migrans with a positive skin or blood culture for Borrelia burgdorferi were enrolled in a prospective study beginning in 1991 and followed up at 6 months and annually thereafter to determine the long-term outcome of this infection. The genotype of the infecting strain of B. burgdorferi was evaluated in subjects with PTLDS. RESULTS: One hundred twenty-eight subjects with culture-confirmed early Lyme disease, of whom 55% were male, were followed for a mean ± SD of 14.98 ± 2.71 years (median = 15 years; range = 11-20 years). Fourteen (10.9%) were regarded as having possible PTLDS, but only 6 (4.7%) had PTLDS documented at their last study visit. Nine (64.3%) had only a single symptom. None of the 6 with PTLDS at their last visit was considered to be functionally impaired by the symptom(s). PTLDS was not associated with a particular genotype of B. burgdorferi. CONCLUSIONS: PTLDS may persist for >10 years in some patients with culture-confirmed early Lyme disease. Such long-standing symptoms were not associated with functional impairment or a particular strain of B. burgdorferi.
Assuntos
Borrelia burgdorferi/isolamento & purificação , Eritema/etiologia , Eritema/patologia , Doença de Lyme/tratamento farmacológico , Doença de Lyme/patologia , Adulto , Idoso , Sangue/microbiologia , Borrelia burgdorferi/classificação , Borrelia burgdorferi/genética , Feminino , Genótipo , Humanos , Doença de Lyme/microbiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Pele/microbiologia , Fatores de Tempo , Resultado do TratamentoRESUMO
BACKGROUND: There are numerous methods currently available for the management of xanthelasma. These include surgical excision, laser ablation using a variety of lasers and chemical cauterization. However, each method of treatment is associated with particular limitations and side effects. OBJECTIVES: To assess the clinical efficacy and tolerability of different concentrations of topical trichloroacetic acid (TCA) vs. carbon dioxide laser in the treatment of patients with xanthelasma palpebrarum. METHODS: Thirty patients with xanthelasma palpebrarum were classified into four groups, treated by TCA 35%, 50%, 70%, and CO2 laser, respectively. Lipid profile was estimated for all patients. RESULTS: Both TCA peeling 70% and carbon dioxide laser ablation showed more significant clinical efficacy and tolerability with least number of sessions in the treatment of xanthelasma palpebrarum than 50% and 35% TCA peeling. Post-therapy erythema and hypopigmentation were more with TCA 70%. Post-therapy hyperpigmentation was more with TCA (50%). There was a significant improvement in patients with normal lipid profile than those with abnormal profile. CONCLUSION: Both TCA peeling 70% and carbon dioxide laser ablation are highly effective and well tolerated with least number of sessions in the treatment of xanthelasma palpebrarum.
Assuntos
Fármacos Dermatológicos/administração & dosagem , Dermatoses Faciais/terapia , Lasers de Gás/uso terapêutico , Ácido Tricloroacético/administração & dosagem , Xantomatose/terapia , Administração Cutânea , Adulto , Abrasão Química , Fármacos Dermatológicos/efeitos adversos , Eritema/etiologia , Dermatoses Faciais/tratamento farmacológico , Dermatoses Faciais/metabolismo , Feminino , Humanos , Hipopigmentação/etiologia , Lasers de Gás/efeitos adversos , Metabolismo dos Lipídeos , Ácido Tricloroacético/efeitos adversos , Xantomatose/tratamento farmacológico , Xantomatose/metabolismoRESUMO
BACKGROUND: Facial erythema is a primary feature of rosacea. Currently, no validated scales exist that can accurately capture a patient's self-assessment of their own facial erythema. During phase 2 studies for brimonidine tartrate gel, a 5-point numeric rating scale was developed as a tool to allow subjects to provide an independent assessment of visible changes to the facial erythema associated with their rosacea. OBJECTIVE: The objective of this study was to validate the revised patient's self-assessment (PSA) scale and evaluate it for statistical reliability and validity in quantification of facial erythema of rosacea. METHODS: The validity of the PSA scale was evaluated by assessing the test-retest reliability, construct validity, and known-groups validity based on the data collected during a Phase 2b study on brimonidine gel for the treatment of persistent facial erythema of rosacea. RESULTS: Based on the results of this evaluation, this PSA scale demonstrated test-retest reliability, construct validity, and known-groups validity. LIMITATIONS: Study results are most generalizable to those with moderate to severe erythema. CONCLUSION: The PSA is an appropriate scale to assess facial erythema associated with rosacea.
Assuntos
Autoavaliação Diagnóstica , Eritema/diagnóstico , Dermatoses Faciais/diagnóstico , Rosácea/tratamento farmacológico , Índice de Gravidade de Doença , Adolescente , Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico , Adulto , Tartarato de Brimonidina/uso terapêutico , Método Duplo-Cego , Eritema/etiologia , Dermatoses Faciais/tratamento farmacológico , Dermatoses Faciais/etiologia , Feminino , Géis , Humanos , Masculino , Reprodutibilidade dos Testes , Rosácea/complicações , Adulto JovemRESUMO
BACKGROUND AND OBJECTIVE: Seborrheic keratoses (SK) are benign cutaneous lesions frequently seen in old age. The aim of the study is to compare the efficiency of Er:YAG lasers with cryotherapy in the treatment of SK. PATIENTS AND METHODS: The study was carried out on 42 patients with SK sized 0.5-3 cm, located on the back, chest, face and neck. Lesions with a similar size and location on the same patient were matched. In the same session, half of the lesions were treated with cryotherapy, while the other half were treated with Er:YAG lasers. All of the patients were clinically evaluated in two recalls with a one-month interval between appointments. The efficiency of the treatments was clinically evaluated. RESULTS: Following the first treatment, complete healing was detected in all of the lesions (100%) treated with Er:YAG lasers, while the healing rate was 68% in the cryotherapy group (p < 0.01). In the Er:YAG laser-treated group, hyperpigmentation was significantly lower and more erythema developed than in the cryotherapy group. CONCLUSION: Er:YAG lasers offer a one-step procedure which is a very simple and economic treatment and provides an alternative treatment method with better cosmetic results compared to cryotherapy.
Assuntos
Crioterapia/métodos , Ceratose Seborreica/cirurgia , Terapia a Laser/métodos , Lasers de Estado Sólido/uso terapêutico , Pele/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Crioterapia/economia , Érbio , Eritema/etiologia , Face , Feminino , Humanos , Hiperpigmentação/etiologia , Terapia a Laser/economia , Masculino , Pessoa de Meia-Idade , Pescoço , Estudos Prospectivos , Resultado do Tratamento , CicatrizaçãoRESUMO
BACKGROUND: Despite the effectiveness of low-fluence Q-switched Nd:YAG laser (QSNY) treatment in melasma, adverse events, including mottled hypopigmentation (MH) and rebound hyperpigmentation (RH) have been reported. OBJECTIVE: To compare the effectiveness and safety of combination therapy using low-fluence QSNY and long-pulse Nd:YAG laser (LPNY) (Dual toning), with low-fluence QSNY monotherapy (QS toning), in Asian melasma patients. MATERIALS AND METHODS: Patients were treated for 10 sessions at 1-week intervals with QSNY (6 mm spot); 2.5-3.0 J/cm(2) for QS toning (n = 177) or 2.1-2.5 J/cm(2) for dual toning (n = 183). The dual toning group was immediately treated with LPNY (7 mm spot, 15-17 J/cm(2)). The results were evaluated using the modified Melasma Area and Severity Index (mMASI) score and the physician's global assessment. RESULTS: MH or RH were significantly lower (1.1% vs. 14.1%) and the treatment efficacy was improved (median decrease of mMASI, 3.6 vs. 3.0) in the dual toning group compared with the QS toning group. Periorbital melasma showed distinctively high rates of adverse events in the QS toning group (23.9% vs. 5.7%), which were significantly reduced in the dual toning group (2.9%). CONCLUSION: Dual toning could represent a safe and effective treatment for Asian melasma patients, as it is associated with minimal adverse events and improved treatment efficacy compared with QS toning monotherapy.